Mariana Bartolome-Yanez
Barcelona, CT 08035, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Genome-wide CRISPR screen identifies AMBRA1 as a potential biomarker of response to platinum-based therapies in oral squamous cell carcinomas.
Journal: iScience
Published: January 12, 2026
Anticancer activity of RAS-GTP inhibition in cholangiocarcinoma.
Journal: Cancer cell
Published: June 18, 2025
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts.
Journal: Signal transduction and targeted therapy
Published: September 02, 2024
SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma.
Journal: Science translational medicine
Published: May 15, 2024
Generation of Metastatic Cholangiocarcinoma Patient-Derived Xenograft Models.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 27, 2024
The potential of patient-derived organoids in precision medicine of biliary tract cancer.
Journal: Cell reports. Medicine
Published: October 16, 2023
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 16, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026